PATENT CLAIM ANALYSIS

Application Number: 15892973
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "685000"]

Abstract:
Methods for the treatment of mood disorders and/or skin disease or damage (eczema, atopic dermatitis, or wrinkles, for example) can comprise administering an extracted prenylflavonoid to a subject experience the mood disorder or the skin disease or damage.

Claim (Index 3):
The method of  claim 1 , wherein the prenylflavonoid is xanthohumol.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 88.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14791181', '14419633', '14016265', '12654596', '11928917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7384192561856002
- 35 USC 102 Novelty (BERT): 0.4915815008541416
- Combined Prediction Score: 0.7137354806524544
- Mean Citation Score: 127.86551
- Max Citation Score: 147.35075
- Similarity Product: 91.6768957425952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test